Premium
Lobaplatin inhibits prostate cancer progression in part by impairing AR and ERG signal
Author(s) -
Hofer Matthias D.
Publication year - 2018
Publication title -
fundamental and clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.655
H-Index - 73
eISSN - 1472-8206
pISSN - 0767-3981
DOI - 10.1111/fcp.12410
Subject(s) - prostate cancer , cancer , medicine , citation , library science , computer science